Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Cerilliant
McKesson
Daiichi Sankyo
AstraZeneca
Cipla
Argus Health
Boehringer Ingelheim

Generated: June 21, 2018

DrugPatentWatch Database Preview

PERRIGO NEW YORK Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO NEW YORK, and when can generic versions of PERRIGO NEW YORK drugs launch?

PERRIGO NEW YORK has sixty approved drugs.

There is one US patent protecting PERRIGO NEW YORK drugs.

There are five patent family members on PERRIGO NEW YORK drugs in five countries and eighteen supplementary protection certificates in nine countries.

Summary for PERRIGO NEW YORK
International Patents:5
US Patents:1
Tradenames:30
Ingredients:29
NDAs:60
Patent Litigation for PERRIGO NEW YORK: See patent lawsuits for PERRIGO NEW YORK

Drugs and US Patents for PERRIGO NEW YORK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo New York CICLOPIROX ciclopirox CREAM;TOPICAL 077364-001 Mar 3, 2006 AB RX No No ➤ Sign Up ➤ Sign Up
Perrigo New York HYDROCORTISONE hydrocortisone OINTMENT;TOPICAL 084969-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Perrigo New York CICLOPIROX ciclopirox SOLUTION;TOPICAL 077623-001 Sep 18, 2007 AT RX No No ➤ Sign Up ➤ Sign Up
Perrigo New York DESONIDE desonide CREAM;TOPICAL 017010-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for PERRIGO NEW YORK Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
269 Luxembourg ➤ Sign Up PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE
C0038 France ➤ Sign Up PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB97/064 United Kingdom ➤ Sign Up PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
1304992/01 Switzerland ➤ Sign Up PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Express Scripts
Dow
Teva
Merck
Moodys
US Department of Justice
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.